Gosogliptin is an oral antidiabetic medication belonging to the class of DPP-4 inhibitors. It is used to treat adults with Type 2 diabetes mellitus, especially when diet and exercise alone are insufficient to control blood glucose. It is grouped under the following drug class(es): DPP-4 inhibitors. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Gosogliptina and Gosogliptine. Its PubChem CID is 11516136.
Gosogliptin
| CAS No | 869490-23-3 |
|---|---|
| Molecular Formula | C17H24F2N6O |
| Molecular Weight | 366.4 g/mol |
| Synonyms | (3,3-difluoropyrrolidin-1-yl)-[(2S,4S)-4-(4-pyrimidin-2-ylpiperazin-1-yl)pyrrolidin-2-yl]methanone |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Gosogliptin is an oral antidiabetic medication belonging to the class of DPP-4 inhibitors. It is used to treat adults with Type 2 diabetes mellitus, especially when diet and exercise alone are insufficient to control blood glucose.
The listed CAS number is 869490-23-3.
The listed molecular formula is C17H24F2N6O.
The listed molecular weight is 366.4 g/mol.
(3,3-difluoropyrrolidin-1-yl)-[(2S,4S)-4-(4-pyrimidin-2-ylpiperazin-1-yl)pyrrolidin-2-yl]methanone.
The source lists Gosogliptina and Gosogliptine.